Stabilized 44-amino-acid GHRH analog. Identity confirmed by LC-MS on every lot.
$96/ 10mg
Figures are illustrative of published preclinical research and are provided for orientation only. They are not claims about this product.
Tesamorelin is a stabilised 44–amino-acid analog of growth hormone-releasing hormone, modified at the N-terminus with a trans-3-hexenoyl group that improves resistance to enzymatic degradation. It is the largest peptide in our catalog and identity is confirmed by LC-MS on every lot.
Signalling pathways examined in preclinical models. Descriptive of published research directions, not claims of effect.
Characterised against the growth hormone-releasing hormone receptor, retaining the full 44-residue sequence of the native hormone.
The trans-3-hexenoyl modification at the N-terminus is the structural feature responsible for improved resistance to dipeptidyl peptidase cleavage.
Used as a full-length GHRH analog reference in preclinical endocrine work.
Valuable as a characterised standard when developing methods for peptides above 40 residues.
Illustrative of published preclinical findings. Not a representation of this product’s performance, and not a claim of any effect in humans.
HPLC purity
RP-HPLC, 214 nm
Identity
LC-MS
Endotoxin (LAL)
Kinetic chromogenic
Heavy metals
ICP-MS
Net peptide content
Nitrogen analysis
Residual solvents
Headspace GC
Lot LP-2601-F
At 44 residues it is by a wide margin the longest peptide in our catalog. Synthesis yield falls and purification difficulty rises sharply with chain length, which is reflected in the price.
Store the sealed vial at −20°C for long-term stability and 2–8°C for short-term handling. Protect from light and avoid repeated freeze-thaw cycles. Compound-specific stability data is printed on the certificate of analysis supplied with the lot.
This material is supplied as a reference standard for in-vitro laboratory research only. It has not been evaluated by the FDA, is not a drug, and is not intended for human or veterinary use. Handling should follow your institution's chemical hygiene plan, including appropriate PPE and documented disposal.
Independent published research relating to this compound. Listed for reference; Lumen Peptides, Inc. is not affiliated with these authors and makes no claims based on their findings.
Effects of tesamorelin on visceral adipose tissue
Falutz J et al. · 2010 · AIDS
Effects of tesamorelin on inflammatory markers
Stanley TL et al. · 2011 · J Clin Endocrinol Metab
For laboratory research use only. All compounds listed on this site are sold strictly as reference materials for in-vitro laboratory research conducted by qualified professionals. They are not drugs, foods, cosmetics, or medical devices. They are not intended for human or veterinary consumption, therapeutic use, diagnostic application, or any in-vivo use whatsoever. These statements have not been evaluated by the Food and Drug Administration. By purchasing, you affirm that you are a qualified researcher and that you will comply with all applicable institutional, local, state and federal regulations governing the handling of research chemicals.
Compounds supplied through this catalog are reference materials for in-vitro laboratory research. Confirm your status to continue.
HELLO STIO 👋
Hey handsome — I built you a website.
— Rob
By entering you agree to our Terms & Research-Use Policy. These products have not been evaluated by the FDA and are not for human consumption. © 2026 Lumen Peptides, Inc.
Analytics cookies
We’d like to measure how the catalog is used, which sets cookies and shares activity with Meta. Nothing loads until you choose, and declining does not affect your order. Privacy policy